What's Trending

Your source for perspectives, case studies and resources on the trends shaping oncology and cardiology benefit management

  • Trends Impacting the Future of Cancer Care

    Trends Impacting the Future of Cancer Care

    Our VP of market strategy shares her insights with Becker's Hospital Review.

    Listen to Podcast
  • Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

    Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

    Our associate CMO writes in ASCO Post about an often-overlooked skill.

    Read External Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Acquisition of Specialty Benefit Management Organization NIA Now Complete

    Acquisition of Specialty Benefit Management Organization NIA Now Complete

    Evolent Health's acquisition adds to a broad and integrated set of value-based specialty solutions.

    Read Article
  • Dr. Monica Soni Selected to Participate in the Carol Emmott Fellowship

    Dr. Monica Soni Selected to Participate in the Carol Emmott Fellowship

    Our associate chief medical officer is among the few women leaders in healthcare chosen for this prestigious experience.

    Read External Article
  • Let's Go
  • Embracing Hope, Naming the Uncomfortable, and Empowering the Patient in Palliative Care

    Embracing Hope, Naming the Uncomfortable, and Empowering the Patient in Palliative Care

    Our CMO Dr. Monica Soni, and American Cancer Society's Chief Patient Officer Dr. Arif Kamal discuss current challenges and the future of effective palliative care.

    Watch Video
  • A Call for Creativity: The Shades of Gray in Delivery of Goal-Concordant Care

    A Call for Creativity: The Shades of Gray in Delivery of Goal-Concordant Care

    Our associate CMO writes for the ASCO Post about the lessons she learned from a loved one's experience with terminal cancer.

    Read External Article
  • Up, Up and Not Going Away: Cancer Drug Prices

    Up, Up and Not Going Away: Cancer Drug Prices

    Our chief medical officer speaks with Managed Healthcare Executive about the financial toxicity of cancer treatment.

    Read External Article
  • When Equality and Health Equity Diverge

    When Equality and Health Equity Diverge

    Treating patients the same isn't always the path to improved outcomes, writes our associate chief medical officer.

    Read Article
  • People with Terminal Cancer Need to Know They Are Dying

    People with Terminal Cancer Need to Know They Are Dying

    Our associate chief medical officer writes in STAT on the need for greater transparency by physicians.

    Read External Article
  • Evolent Health, Parent Company of New Century Health, to Acquire IPG

    Evolent Health, Parent Company of New Century Health, to Acquire IPG

    The acquisition of IPG expected to accelerate Evolent Health's position as a leading provider of value-based specialty care solutions.

    Read Article
  • New Century Health and Humana Surpass Monumental 10 Years of Partnership in High-Value Oncology Care

    New Century Health and Humana Surpass Monumental 10 Years of Partnership in High-Value Oncology Care

    New Century Health and Humana's national partnership improves patient experience and eases administrative burdens on provider practices.

    Read Press Release
  • Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.

    Watch Video
  • Bridging the Gaps in Advance Care Planning in Oncology

    Bridging the Gaps in Advance Care Planning in Oncology

    New Century Health and our Vital Decisions solution seek to ensure more cancer patients receive end-of-life care that aligns with their wishes.

    Read Article
  • New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model

    New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model

    NCH’s high-value clinical oncology pathways, patient triage programs and provider engagement strategies help community practice to succeed in value-based payment program.

    Read Press Release
  • Still Bracing for the Surge in Advanced Cancer Cases

    Still Bracing for the Surge in Advanced Cancer Cases

    The predicted wave of late-stage cancers is taking longer to materialize than we expected.

    Read Article
  • Cancer Moonshot 2.0: Three Big Questions to Track

    Cancer Moonshot 2.0: Three Big Questions to Track

    Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.

    Read Article
  • The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.

    Listen to Podcast
  • Targeting Overuse, Misuse and Underuse in Cardiovascular Care: Why Health Plans Need a Comprehensive Strategy

    Targeting Overuse, Misuse and Underuse in Cardiovascular Care: Why Health Plans Need a Comprehensive Strategy

    Learn key strategies for health plans to reduce three types of inappropriate use in cardiovascular care.

    Read Insight Brief
  • Developing a playbook to tackle health inequities in cancer care

    Developing a playbook to tackle health inequities in cancer care

    New Century Health Associate Chief Medical Officer Monica Soni explores health inequities in cancer cares and shares strategies for how to address them.

    Watch Video
  • Accelerated Drug Approvals Present a Mounting Challenge to Oncologists

    Accelerated Drug Approvals Present a Mounting Challenge to Oncologists

    Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.

    Read External Article
  • loading
    Loading More...